A.A. Ajazova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A.A. Ajazova has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- D. Yu. Kanner
Moscow City Oncology Hospital No. 62
1 shared publication - Dmitry Suraev
Moscow City Oncology Hospital No. 62
1 shared publication - Nikita A. Savelov
Moscow City Oncology Hospital No. 62
1 shared publication - Oksana V. Paklina
Vishnevsky National Medical Research Center of Surgery
1 shared publication - S. О. Zagagov
Moscow City Oncology Hospital No. 62
1 shared publication
Latest Publications
- 12 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (1) , 41-47
Neuroendocrine tumor of the extrahepatic bile ducts. Case report and literature review
Neuroendocrine neoplasms (NENs) are heterogeneous tumors with a common phenotype. There are two fundamentally different groups of NENs: well differentiated with a low proliferative index, called neuroendocrine tumors (NETs) and poorly differentiated with a high proliferative index, called neuroendocrine carcinoma (NEC). Extrahepatic bile duct NETs (EBNETs) account for 0.2% to 2% of all gastrointestinal NETs and up to 2% of all malignant neoplasms of the extrahepatic bile ducts. To date, 114 cases of EBNETs have been described, with disease-free survival ranging from 2 to 240 months. In most cases, the tumors expressed Chromogranin A, Synaptophysin, CD56, and NSE. This report presents a rare case of an EBNET in a 61-year-old patient following resection of the extrahepatic bile ducts. The description includes data from radiological and ultrasound diagnostic methods, macro- and microscopic characteristics of the tumor, and immunohistochemical profile.
- 12 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (1) , 41-47
Neuroendocrine tumor of the extrahepatic bile ducts. Case report and literature review
Neuroendocrine neoplasms (NENs) are heterogeneous tumors with a common phenotype. There are two fundamentally different groups of NENs: well differentiated with a low proliferative index, called neuroendocrine tumors (NETs) and poorly differentiated with a high proliferative index, called neuroendocrine carcinoma (NEC). Extrahepatic bile duct NETs (EBNETs) account for 0.2% to 2% of all gastrointestinal NETs and up to 2% of all malignant neoplasms of the extrahepatic bile ducts. To date, 114 cases of EBNETs have been described, with disease-free survival ranging from 2 to 240 months. In most cases, the tumors expressed Chromogranin A, Synaptophysin, CD56, and NSE. This report presents a rare case of an EBNET in a 61-year-old patient following resection of the extrahepatic bile ducts. The description includes data from radiological and ultrasound diagnostic methods, macro- and microscopic characteristics of the tumor, and immunohistochemical profile.